Vanguard Group »

Cytek Biosciences shares owned by Vanguard Group

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $66M 12M 5.58
2024-03-31 $81M 12M 6.71
2023-12-31 $108M 12M 9.12
2023-09-30 $61M 11M 5.52
2023-06-30 $91M 11M 8.54
2023-03-31 $73M 7.9M 9.19
2022-12-31 $79M 7.8M 10.21
2022-06-30 $67M 6.3M 10.73
2022-03-31 $69M 6.4M 10.78
2021-09-30 $26M 1.2M 21.41